Catalyst Funds Management Pty Ltd Takes Position in Grail, Inc. (NASDAQ:GRAL)

Catalyst Funds Management Pty Ltd purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 12,500 shares of the company’s stock, valued at approximately $223,000.

A number of other hedge funds also recently made changes to their positions in the business. Wellington Shields & Co. LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $190,000. Wellington Shields Capital Management LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $33,000. Commonwealth Equity Services LLC bought a new stake in Grail during the fourth quarter worth approximately $3,278,000. PGGM Investments bought a new stake in Grail during the fourth quarter worth approximately $1,224,000. Finally, Erste Asset Management GmbH bought a new stake in Grail during the fourth quarter worth approximately $120,000.

Insiders Place Their Bets

In other Grail news, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the transaction, the president now owns 559,673 shares in the company, valued at approximately $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the transaction, the chief executive officer now owns 828,662 shares in the company, valued at approximately $25,862,541.02. This trade represents a 0.91 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 11,550 shares of company stock worth $360,436.

Grail Price Performance

Shares of NASDAQ:GRAL opened at $29.74 on Monday. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The stock’s 50 day moving average price is $31.81 and its 200 day moving average price is $21.39.

Grail (NASDAQ:GRAL) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. Research analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Morgan Stanley started coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.